oalib

Publish in OALib Journal

ISSN: 2333-9721

APC: Only $99

Submit

Any time

2020 ( 5 )

2019 ( 235 )

2018 ( 291 )

2017 ( 287 )

Custom range...

Search Results: 1 - 10 of 228664 matches for " C.; Ramos Amador "
All listed articles are free for downloading (OA Articles)
Page 1 /228664
Display every page Item
Tool Proposal for Software Process Assessment Using ISO/IEC 15504  [PDF]
Marcelo Pérez Ramos, Margarita Mondragón Arellano, César Velázquez Amador
Open Access Library Journal (OALib Journal) , 2015, DOI: 10.4236/oalib.1101561
Abstract: In these days, there exist some maturity & capability models, standard methodologies and guidelines to help organizations to improve their processes and the way they work. In software area, there are Software Process Assessment Models like ISO/IEC 15504. This model provides guidance for assessing the organization’s capacity about software development and his maturity on implemented processes. Software Process Assessment models don’t provide systematic metrics for assessing the Software Process. Therefore, this process has to be performed by experienced assessors who use their own subjective estimations for quantitative measures or by using established metrics. This article presents a tool proposal designed for supporting the software process assessment and helps to determine the organization’s capability on his software development process from ISO/ IEC 15504 (SPICE) model perspective.
Disminución del nivel de conciencia: ?causa abdominal?
Orden Izquierdo,E. La; Fernández Ibieta,M.; Cuadrado Pérez,I.; Palomino Mu?oz,C.; Ramos Amador,JT.;
Pediatría Atención Primaria , 2010, DOI: 10.4321/S1139-76322010000100007
Abstract: intussusception is a common cause of acute abdomen and intestinal obstruction in children between 3 months and 6 years old. we describe a case of a 2-year-old child who went to the emergency department for an episode of headache, vomiting and low reactivity to stimuli. after an initial study to rule out potential causes of altered mental status, an abdominal ultrasound gave the diagnosis of ileo-ileal intussusception. the subsequent resolution was spontaneous. abdominal causes should be excluded in the pediatric age in case of changes in level of consciousness that are unexplained by other conditions. abdominal ultrasound is a noninvasive technique that can help the diagnosis.
Resenha: O exercício profissional dos assistentes sociais nas políticas públicas: um debate necessário
Josy Ramos de Oliveira Amador
Em Pauta : Teoria Social e Realidade Contemporanea , 2013,
Abstract: O exercício profissionaldos assistentes sociais nas políticaspúblicas: um debate necessário
Debut oftalmológico de dos casos de estesioneuroblastoma
Díez-Villalba,R.; González-Ruiz,M.; Izquierdo-Vázquez,C.; Molina-Quirós,C.; Colmenero-Ruiz,M.; Ramos-Amador,A.; Jordano-Luna,L.; Mora-de-O?ate,J.; Sanz-Fernández,R.;
Archivos de la Sociedad Espa?ola de Oftalmología , 2008, DOI: 10.4321/S0365-66912008000500007
Abstract: purpose/method: to report the ophthalmologic presentation of two cases of esthesioneuroblastoma (enb). a comprehensive ophthalmic assessment was made, including magnetic resonance imaging. a paranasal sinus mass was biopsied in one case and a nasal mass biopsied in the other. cases report/discussion: two women, aged 85 and 32 years respectively, presented to the emergency room with ophthalmic symptoms and signs. the first reported orbital pain and eyelid edema and the second, who was 22 weeks pregnant, reported a spontaneous lower eyelid haematoma, orbital pain and rhinorrhoea. enb is a rare malignant tumour and its presentation with ophthalmologic symptoms and signs is very infrequent.
Pharmacological and clinical evidence of nevirapine immediate- and extended-release formulations
Ena J, Amador C, Benito C, Pasquau F
HIV/AIDS - Research and Palliative Care , 2012, DOI: http://dx.doi.org/10.2147/HIV.S35564
Abstract: rmacological and clinical evidence of nevirapine immediate- and extended-release formulations Review (1062) Total Article Views Authors: Ena J, Amador C, Benito C, Pasquau F Published Date November 2012 Volume 2012:4 Pages 169 - 179 DOI: http://dx.doi.org/10.2147/HIV.S35564 Received: 03 July 2012 Accepted: 31 August 2012 Published: 15 November 2012 Javier Ena, Concepción Amador, Conxa Benito, Francisco Pasquau HIV Unit, Hospital Marina Baixa, Villajoyosa, Spain Abstract: We reviewed the current information available on nevirapine immediate- and extended-release formulations and its role in single-dose and combination antiretroviral therapy. Nevirapine was approved in 1996 and was the first non-nucleoside reverse-transcriptase inhibitor available for the treatment of HIV-1 infection. Nevirapine has demonstrated good efficacy and a well-characterized safety profile. A major drawback is the low genetic barrier, allowing the emergence of resistance in the presence of single mutations in the reverse-transcriptase gene. This shortcoming is particularly relevant when nevirapine is administered in a single dose to prevent mother-to-child transmission of HIV-1 infection, compromising the efficacy of future non-nucleoside reverse transcriptase–inhibitor regimens. Studies published recently have probed the noninferiority of nevirapine compared to ritonavir-boosted atazanavir with both tenofovir disoproxil fumarate and emtricitabine in antiretroviral treatment–na ve patients. In 2011, a new formulation of nevirapine (nevirapine extended release) that allowed once-daily dosing was approved by the Food and Drug Administration and by the European Medicines Agency. VERxVe, a study comparing nevirapine extended release with nevirapine immediate release in antiretroviral treatment–na ve patients, and TRANxITION, a study carried out in antiretroviral treatment–experienced patients who switched therapy from nevirapine immediate release to nevirapine extended release, provided data on the noninferiority of the new formulation of nevirapine compared with nevirapine immediate release in terms of efficacy and safety. Nevirapine extended release will further increase the durability and persistence of nevirapine-containing antiretroviral therapy, allowing once-daily dosing regimens.
Pharmacological and clinical evidence of nevirapine immediate- and extended-release formulations
Ena J,Amador C,Benito C,Pasquau F
HIV/AIDS - Research and Palliative Care , 2012,
Abstract: Javier Ena, Concepción Amador, Conxa Benito, Francisco PasquauHIV Unit, Hospital Marina Baixa, Villajoyosa, SpainAbstract: We reviewed the current information available on nevirapine immediate- and extended-release formulations and its role in single-dose and combination antiretroviral therapy. Nevirapine was approved in 1996 and was the first non-nucleoside reverse-transcriptase inhibitor available for the treatment of HIV-1 infection. Nevirapine has demonstrated good efficacy and a well-characterized safety profile. A major drawback is the low genetic barrier, allowing the emergence of resistance in the presence of single mutations in the reverse-transcriptase gene. This shortcoming is particularly relevant when nevirapine is administered in a single dose to prevent mother-to-child transmission of HIV-1 infection, compromising the efficacy of future non-nucleoside reverse transcriptase–inhibitor regimens. Studies published recently have probed the noninferiority of nevirapine compared to ritonavir-boosted atazanavir with both tenofovir disoproxil fumarate and emtricitabine in antiretroviral treatment–na ve patients. In 2011, a new formulation of nevirapine (nevirapine extended release) that allowed once-daily dosing was approved by the Food and Drug Administration and by the European Medicines Agency. VERxVe, a study comparing nevirapine extended release with nevirapine immediate release in antiretroviral treatment–na ve patients, and TRANxITION, a study carried out in antiretroviral treatment–experienced patients who switched therapy from nevirapine immediate release to nevirapine extended release, provided data on the noninferiority of the new formulation of nevirapine compared with nevirapine immediate release in terms of efficacy and safety. Nevirapine extended release will further increase the durability and persistence of nevirapine-containing antiretroviral therapy, allowing once-daily dosing regimens.Keywords: nevirapine extended release, efficacy, safety, resistance, clinical practice
Factores metabólicos asociados con la progresión hacia la diabetes mellitus en sujetos con tolerancia a la glucosa alterada
González Suárez,Roberto M.; Perich Amador,Pedro; Valdés Ramos,Eduardo; Arranz Calzado,Celeste;
Revista Cubana de Endocrinolog?-a , 2007,
Abstract: a prospective study was conducted in 84 patients with impaired glucose tolerance (igt) diagnosed 18 years before to identify metabolic factors found in the initial study that could be associated with the progression to diabetes mellitus (dm) detected in the evolutive study. the severity of the glucose tolerance disorder, the reduction or increase of insulin secretion on fasting or during an oral glucose tolerance test (ogtt), as well as the resistance to insulin detected on fasting or during the ogtt, were considered as risk factors. all of them were determined by methods and criteria of interpretation that were previously established and validated. it was observed that a low initial insulin response (reduced ii0-30) was significantly associated with the progression to diabetes in the group of studied individuals with igt. this finding was consistent with all the aspects of the evaluated phenomenon (absolute values of the variables in the group of subjects classified according to their evolution, risk of evolution toward diabetes mellitus and time elapsed until the diagnosis of dm) and agreed with the criteria that the genetically determined factor that conditions the development of dm is a defect of the initial capacity of the insulin secretory response to glycaemia changes.
Calidad de vida en pacientes con insuficiencia renal crónica en tratamiento con diálisis
Seguí Gomà,Anna; Amador Peris,Patricia; Ramos Alcario,Ana Belén;
Revista de la Sociedad Espa?ola de Enfermería Nefrológica , 2010, DOI: 10.4321/S1139-13752010000300002
Abstract: introduction: during last decade there have been developed several studies aimed to evaluate life quality (lq) related with health in patients with chronic renal failure (crf) under dialysis substitutive treatment. aim: to evaluate lq and personal characteristics of patients with crf and compare it with general population. material and methods: a cross section descriptive study based on a sample of 96 patients of dialysis in a centre in tarragona. the form sf-36 was used to check lq. results were compared with the general references of spanish population. the following data were taken into account: age, sex, marital status, profession, address, time needed to arrive to the dialysis center, transport used to get to the dialysis centre, time under treatment and vascular access. results: the average age of the study is 62,12 years old in a range between 18 and 90. there are more males (53,1%); the 66,7% is married; 60,4% is retired and 88,6% lives with someone. it has been also compared the time needed to arrive to the dialysis centre and the transport used: the 55,2% uses ambulance. the 65,6% is internal arteriovenous fistula carrier. conclusions: life quality in patients of crf is worst than in reference population in all dimensions.
Factores metabólicos asociados con la progresión hacia la diabetes mellitus en sujetos con tolerancia a la glucosa alterada Metabolic factors associated with the progression of diabetes mellitus in subjects with impaired glucose tolerance
Roberto M. González Suárez,Pedro Perich Amador,Eduardo Valdés Ramos,Celeste Arranz Calzado
Revista Cubana de Endocrinología , 2007,
Abstract: Se realizó un estudio prospectivo en 84 pacientes con tolerancia a la glucosa alterada (TGA), diagnosticada 18 a os antes, para identificar factores metabólicos identificados en el estudio inicial, que pudieran estar asociados a la progresión hacia la diabetes mellitus (DM) detectada en el estudio evolutivo. Como factores de riesgo metabólicos se consideraron la gravedad del trastorno de la tolerancia a la glucosa, la disminución o incremento de la secreción de insulina en ayunas y durante una PTG oral, así como la resistencia a la insulina detectada en ayunas o durante la PTG, todos ellos determinados con métodos y criterios de interpretación previamente establecidos y validados. Se encontró que la presencia de una baja respuesta insulínica inicial (II0-30 disminuido) se asocia significativamente con la progresión hacia la diabetes en el grupo de sujetos con TGA estudiados. Este hallazgo es consistente en todos los aspectos del fenómeno evaluado (valores absolutos de las variables en los grupos de sujetos clasificados de acuerdo con su evolución, riesgo de evolución hacia la DM y tiempo hasta el diagnóstico de DM) y está de acuerdo con el criterio de que el factor genéticamente determinado que condiciona el desarrollo de la DM es un defecto de la capacidad inicial de respuesta insulinosecretora a los cambios de la glicemia. A prospective study was conducted in 84 patients with impaired glucose tolerance (IGT) diagnosed 18 years before to identify metabolic factors found in the initial study that could be associated with the progression to diabetes mellitus (DM) detected in the evolutive study. The severity of the glucose tolerance disorder, the reduction or increase of insulin secretion on fasting or during an oral glucose tolerance test (OGTT), as well as the resistance to insulin detected on fasting or during the OGTT, were considered as risk factors. All of them were determined by methods and criteria of interpretation that were previously established and validated. It was observed that a low initial insulin response (reduced II0-30) was significantly associated with the progression to diabetes in the group of studied individuals with IGT. This finding was consistent with all the aspects of the evaluated phenomenon (absolute values of the variables in the group of subjects classified according to their evolution, risk of evolution toward diabetes mellitus and time elapsed until the diagnosis of DM) and agreed with the criteria that the genetically determined factor that conditions the development of DM is a defect of the initial capacity of the insu
Calidad de vida en pacientes con insuficiencia renal crónica en tratamiento con diálisis Quality of life in patients with chronic renal insufficiency undergoing dialysis
Anna Seguí Gomà,Patricia Amador Peris,Ana Belén Ramos Alcario
Revista de la Sociedad Espa?ola de Enfermería Nefrológica , 2010,
Abstract: Introducción: En la última década, han proliferado los estudios para evaluar la calidad de vida relacionada con la salud en pacientes con Insuficiencia Renal Crónica en tratamiento sustitutivo con diálisis. Objetivo: Evaluar la CV y las características personales de pacientes con IRC y comparar con la población general. Material y método: Estudio descriptivo de corte transversal con una muestra de 96 pacientes en diálisis de un centro de Tarragona. Para hacer la valoración de la Calidad de Vida utilizamos el cuestionario de salud SF-36 y lo comparamos con los valores normales de referencia de la población espa ola. Se valoran los siguientes datos: edad, sexo, estado civil, profesión, lugar donde vive, tiempo que tarda en llegar al centro de diálisis, transporte utilizado, tiempo que lleva en tratamiento y por último el acceso vascular. Resultados: La edad media del estudio es de 62,12 a os en un rango comprendido entre 18 y 90 a os. Predominan los varones con un 53,1%. El 66,7% están casados, unos 60,4% jubilados y el 88,6% viven acompa ados. También hemos comparado según el trayecto a realizar hasta la unidad, tiempo que tardan y el tipo de transporte que utilizan siendo el 55,2% que se desplazan en ambulancia. Para finalizar, el 65,6% son portadores de FAVI. Conclusiones: La calidad de vida en pacientes con IRCT, es peor que la población de referencia en todas las dimensiones. Introduction: During last decade there have been developed several studies aimed to evaluate Life Quality (LQ) related with health in patients with Chronic Renal Failure (CRF) under dialysis substitutive treatment. Aim: To evaluate LQ and personal characteristics of patients with CRF and compare it with general population. Material and methods: A cross section descriptive study based on a sample of 96 patients of dialysis in a centre in Tarragona. The form SF-36 was used to check LQ. Results were compared with the general references of Spanish population. The following data were taken into account: age, sex, marital status, profession, address, time needed to arrive to the dialysis center, transport used to get to the dialysis centre, time under treatment and vascular access. Results: The average age of the study is 62,12 years old in a range between 18 and 90. There are more males (53,1%); the 66,7% is married; 60,4% is retired and 88,6% lives with someone. It has been also compared the time needed to arrive to the dialysis centre and the transport used: the 55,2% uses ambulance. The 65,6% is internal arteriovenous fistula carrier. Conclusions: Life Quality in patients of CRF i
Page 1 /228664
Display every page Item


Home
Copyright © 2008-2017 Open Access Library. All rights reserved.